P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 10, 2007, Pages 883-889

  Mitomi, Hiroyuki ^a   Ohkura, Yasuo ^b   Fukui, Naoshi ^a   Kanazawa, Hideki ^a   Kishimoto, Ichiro ^a   Nakamura, Takatoshi ^c   Yokoyama, Kaoru ^c   Sada, Miwa ^c   Kobayashi, Kiyonori ^c   Tanabe, Satoshi ^c   Saigenji, Katsunori ^c  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal carcinoma; Kras; Multivariate analysis; P21WAF1 CIP1; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; FLUOROURACIL; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; COLORECTAL CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; OUTCOME ASSESSMENT; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VOLUME; ADENOCARCINOMA; COLORECTAL TUMOR; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MUTATION; PATHOLOGY; SURVIVAL;

ADENOCARCINOMA; AGED; APOPTOSIS; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RAS PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548703583     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282e1c5f3     Document Type: Article

References (35)

1. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266:1821-1828.
2. Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-1677.
3. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-825.
4. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54:1169-1174.
5. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267:1018-1021.
6. Cip1 in muscle and other terminally differentiating cells. Science 1995; 267:1024-1027.
7. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994; 54:3131-3135.
8. Wang Y, Szekely L, Okan I, Klein G, Wiman KG. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 1993; 8:3427-3431.
9. Feig LA. The many roads that lead to ras. Science 1993; 260:767-768.
10. WAF1- dependent mechanism. Oncogene 2000; 19:783-790.
11. INK4a. Cell 1997; 88:593-602.
12. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998; 12:3008-3019.
13. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995; 55:2910-2919.
14. WAF1/Cip1 in colorectal carcinoma. Br J Cancer 1996; 74:165-171.
15. Matsushita K, Kobayashi S, Kato M, Itoh Y, Okuyama K, Sakiyama S, et al. Reduced messenger RNA expression level of p21CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation. Int J Cancer (Pred Oncol) 1996; 69:259-264.
16. Doglioni C, Pelosio P, Laurino L, Macri E, Meggiolaro E, Favretti F, et al. p21/waf1/cip1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relation with differentiation. J Pathol 1996; 179:248-253.
17. waf1/cip1/sdi1 and p53 proteins in formalin-fixed, paraffin-embedded tissue sections of colorectal carcinoma. Hum Pathol 1996; 27:912-916.
18. Wang A, Yoshimi N, Ino N, Tanaka T, Mori H. WAF1 expression and p53 mutations in human colorectal cancers. J Cancer Res Clin Oncol 1997; 123:118-123.
19. WAF1/CIP1, and bcl-2 in radioresistant colorectal carcinoma. Hum Pathol 1997; 28:1189-1195.
20. WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Pathol Int 1997; 47:470-477.
21. WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers. Clin Cancer Res 1998; 4:1251-1261.
22. WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations. J Pathol 1999; 187:302-307.
23. Ropponen KM, Kellokoski JK, Lipponen PK, Pietiläinen T, Eskelinen MJ, Alhava EM, et al. p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Br J Cancer 1999; 81:133-140.
24. Girlando S, Slomp P, Caffo O, Amichetti M, Togni R, Dvornik G, et al. p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinico-pathological correlations. Virchows Arch 1999; 435:559-565.
25. Bukholm IK, Nesland JM. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 2000; 436:224-228.
26. Veloso M, Wrba F, Kaserer K, Heinze G, Magalhães A, Herbst F, et al. p53 gene status and expression of p53, mdm2, and p21Waf1/Cip1 proteins in colorectal cancer. Virchows Arch 2000; 437:241-247.
27. WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy. Int J Oncol 2002; 21:787-793.
28. WAF1/CIP1 expression in rectal cancer patients. Int J Oncol 2002; 21:1223-1228.
29. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
30. Kip1 of mucinous carcinomas of the colorectum: comparison with well-differentiated type. Am J Clin Pathol 2002; 117:908-915.
31. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res 1996; 226:387-397.
32. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994; 9:3389-3396.
33. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54:3391-3395.
34. Li Y-J, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 1995; 10:599-601.
35. WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene 1995; 11:2311-2316.